Cargando…

Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip

OBJECTIVE: To shorten the natural course of transient osteoporosis of hip (TOH), which is a self-limiting idiopathic condition and requires 6–12 months for the resolution of symptoms, various therapies including treatment with bisphosphonates have been attempted. There exist fewer case reports evalu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agarwala, Sanjay, Vijayvargiya, Mayank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Academy of Rehabilitation Medicine 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637057/ https://www.ncbi.nlm.nih.gov/pubmed/31311253 http://dx.doi.org/10.5535/arm.2019.43.3.314

Ejemplares similares

Predictive factors affecting long-term survivorship of ASR metal-on-metal total hip arthroplasty
por: Agarwala, Sanjay, et al.
Publicado: (2021)

Treatment of Transient Osteoporosis of the Hip with Intravenous Zoledronate - A Case Report -
por: Seok, Hyun, et al.
Publicado: (2011)

Bisphosphonate combination therapy for non-femoral avascular necrosis
por: Agarwala, Sanjay, et al.
Publicado: (2019)

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
por: Chapurlat, Roland D
Publicado: (2009)

Bisphosphonate Combination Therapy in the Management of Postchemotherapy Avascular Necrosis of the Femoral Head in Adolescents and Young Adults: A Retrospective Study From India
por: Agarwala, Sanjay, et al.
Publicado: (2018)

Clinical effect of Zoledronic Acid in the treatment of Senile Osteoporosis
por: Kong, Li, et al.
Publicado: (2020)

A Paradigm Shift in Osteonecrosis Treatment with Bisphosphonates: A 20-Year Study
por: D(Orth), Sanjay Agarwala, et al.
Publicado: (2021)

Transient Osteoporosis of the Hip: Risk and Therapy
por: Bashaireh, Khaldoon M, et al.
Publicado: (2020)

Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel, Agnès, et al.
Publicado: (2011)

Zoledronic acid infusion for prevention and treatment of osteoporosis
por: Sunyecz, John A
Publicado: (2010)

Cost-effectiveness of single-dose zoledronic acid for nursing home residents with osteoporosis in the USA
por: Ito, Kouta
Publicado: (2018)

Traumatic dissociation of the tibial insert with patellar tendon rupture after high-flex posterior-stabilized Genesis II total knee arthroplasty()
por: Agarwala, Sanjay, et al.
Publicado: (2017)

Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis women
por: Chao, Ma, et al.
Publicado: (2013)

Is obesity a contraindication for simultaneous bilateral total knee arthroplasty? A prospective case–control study
por: Agarwala, Sanjay, et al.
Publicado: (2020)

Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation
por: Spångeus, Anna, et al.
Publicado: (2020)

Safety and Efficacy of Zoledronic Acid Treatment with and without Acetaminophen and Eldecalcitol for Osteoporosis
por: Mochizuki, Takeshi, et al.
Publicado: (2021)

Transient osteoporosis of the hip
por: Thomas, Joe, et al.
Publicado: (2019)

Transient osteoporosis of the hip
por: McWalter, Patricia, et al.
Publicado: (2009)

TFNA Implant Failure with Helical Blade Cut-out
por: Agarwala, Sanjay, et al.
Publicado: (2020)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
por: Serefoglu, Ege Can, et al.
Publicado: (2010)

Safety & Efficacy of Cyclic Zoledronic Acid Therapy on Pediatric Secondary Osteoporosis
por: Al-Agha, Abdulmoein E., et al.
Publicado: (2016)

Patellar Resurfacing versus Nonresurfacing with Patellaplasty in Total Knee Arthroplasty
por: Agarwala, Sanjay, et al.
Publicado: (2018)

Single-Dose Therapy of Zoledronic Acid for the Treatment of Primary Bone Marrow Edema Syndrome
por: Vasiliadis, Angelo V, et al.
Publicado: (2021)

Avascular necrosis as a part of ‘long COVID-19’
por: Agarwala, Sanjay R, et al.
Publicado: (2021)

Synergistic effect of graphene oxide and zoledronic acid for osteoporosis and cancer treatment
por: Boran, Gökçen, et al.
Publicado: (2020)

Bisphosphonates for Post-COVID Osteonecrosis of the Femoral Head: Medical Management of a Surgical Condition
por: Agarwala, Sanjay, et al.
Publicado: (2022)

Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis
por: Ringe, Johann D
Publicado: (2010)

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
por: Lewiecki, E Michael
Publicado: (2010)

Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan
por: Moriwaki, K., et al.
Publicado: (2017)

Management of osteoporosis in the aging male: Focus on zoledronic acid
por: Piper, Paul K, et al.
Publicado: (2009)

Six monthly intravenous zoledronic acid in childhood osteoporosis
por: Munns, CF, et al.
Publicado: (2013)

How zoledronic acid improves osteoporosis by acting on osteoclasts
por: Wang, Biao, et al.
Publicado: (2022)

IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
por: Lin, Haiqing, et al.
Publicado: (2021)

Superior functional outcome with dual mobility THR as compared to conventional THR in fracture neck femur: a prospective cohort study
por: Agarwala, Sanjay, et al.
Publicado: (2021)

Development of zoledronic acid functionalized hydroxyapatite loaded polymeric nanoparticles for the treatment of osteoporosis
por: Cai, Yunlu, et al.
Publicado: (2018)

Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients
por: Huang, Chun-Feng, et al.
Publicado: (2021)

Cost-Effectiveness of Zoledronic Acid to Prevent and Treat Postmenopausal Osteoporosis in Comparison with Routine Medical Treatment
por: Golmohamdi, Fateme Rostami, et al.
Publicado: (2016)

Treatment of postmenopausal osteoporosis, patient perspectives – focus on once yearly zoledronic acid
por: Carmona, Raj, et al.
Publicado: (2009)

Symptomatic Hypocalcemia Associated with Zoledronic Acid Treatment for Osteoporosis: A Case Report
por: Al Elq, Abdulmohsen H.
Publicado: (2013)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
por: Dalle Carbonare, Luca, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1mdgpeahg755okn6972kqd2rng